Medicine and Dentistry
Prognostic Factor
100%
Neoplasm
96%
Thyroidectomy
70%
Thyroid Nodule
53%
Recurrent Disease
44%
Cross Sectional Study
37%
Survival Rate
37%
COVID-19
33%
Secondary Hyperparathyroidism
33%
Skin Cancer
33%
Cell Marker
33%
Suture Material
33%
Seroma
33%
Wide Local Excision
33%
Parathyroid Carcinoma
33%
Modified Radical Mastectomy
33%
Cancer Stem Cell
33%
Chronic Kidney Disease
33%
Mouth Squamous Cell Carcinoma
33%
Non Melanoma Skin Cancer
33%
Retrospective Study
33%
Triple Negative Breast Cancer
33%
Xeroderma pigmentosum
33%
Neck
26%
Parathyroid Hormone
25%
Cancer
22%
Breast Cancer
20%
Thyroid Tumor
15%
Overall Survival
14%
Clinical Stage
14%
Lymph Node
13%
Malignant Neoplasm
13%
Survival Analysis
13%
Parathyroid
13%
Hyperparathyroidism
11%
Parathyroidectomy
11%
Middle Finger
11%
Surgeon
10%
Disease Specific Survival
9%
Disease
9%
Perineural Invasion
9%
Medical Record
8%
Lymph Node Metastasis
8%
Stem Cell
8%
Body Mass Index
8%
Osteoclast Activity
6%
Tumor Recurrence
6%
Hoarseness
6%
Hard Palate
6%
Postoperative Complication
6%
Keyphrases
Prognostic Factors
100%
Indonesia
40%
Survival Rate
36%
Tumor
33%
Indeterminate Thyroid Nodules
33%
Skin Cancer
33%
Triple-negative Breast Cancer
33%
Recurrence Factor
33%
Wide Local Excision
33%
Non-melanoma Skin Cancer
33%
Parathyroid Carcinoma
33%
Skin Closure
33%
Rate Factor
33%
Single-center Retrospective Study
33%
COVID-19 Pandemic
33%
Thyroidectomy
33%
Axillary Breast
33%
Endoscopic Thyroidectomy
33%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
33%
Purse-string Suture
33%
Multicenter Cross-sectional Study
33%
Cancer Stem Cell Markers
33%
Flap Transfer
33%
Failure Report
33%
Aldehyde Dehydrogenase 2 (ALDH2)
33%
Xeroderma pigmentosum
33%
Suture Techniques
26%
Purse-string
26%
Excisional Surgery
19%
Neck Ultrasound
16%
Thyroid Tumor
15%
Satisfaction Level
13%
Breast Cancer Patients
13%
Survival Analysis
12%
Pre-pandemic
12%
Facial Resurfacing
11%
Postoperative Monitoring
11%
Disease-specific Survival
9%
Basal Cell Carcinoma
9%
Overall Survival Rate
9%
Perineural Invasion
9%
Advanced Stage
8%
Medical Records
8%
Malignancy
8%
Structural Disease
8%
Surgical Activity
8%
Lymph Node Metastasis
8%
High Risk
8%
Recurrent Disease
8%
Sestamibi Scan
8%